Sarah Morale
May 1, 2016
Related Articles
Retina Foundation Announces 2023 Visionary Luncheon and Sets $1 Million Fundraising Goal Early Detection and Treatment for Pediatric Eye Conditions – Video Update Retina Foundation to Conduct First Optogenetics Gene Therapy Clinical Trial 20 Years of Racing for Sight Promising Results From Ongoing Phase 1/2 Clinical Trial for X-Linked Retinitis Pigmentosa (XLRP)